Announcements Trials
Browse Landscape

Phase

Phase 1 17Phase 2 14Phase 4 11Phase 3 8Phase NA 5Phase 1/2 5Phase EARLY_PHASE1 4Phase 2/3 2

Status

Completed 4Unknown 2Terminated 2

Sponsor Class

INDUSTRY 9OTHER 8NETWORK 2NIH 1

Study Type

Interventional 8

Sponsor

Cancer Type

Gynecologic 3Other neoplasm 1Dermatologic 1

Conditions

Uterine Cervical Dysplasia 3Precancerous Conditions 1Patient Satisfaction 1Paget Disease, Extramammary 1Keratosis, Actinic 1Hutchinson's Melanotic Freckle 1Condylomata Acuminata 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Imiquimod × Clear all
NCT02394132 2024-06-20

RADICAL

Melanoma and Skin Cancer Trials Limited

Phase 3 Completed
126 enrolled

Hutchinson's Melanotic Freckle

NCT01861535 2021-04-14

PITVIN

Medical University of Graz

Phase 3 Completed
110 enrolled

Patient Satisfaction

NCT03289260 2020-09-23

AdAM

Medical University Innsbruck

Phase 3 Unknown
200 enrolled

Condylomata Acuminata

NCT02385188 2020-01-02

Topical 5% Imiquimod Cream for Vulvar Paget's Disease

University Medical Center Nijmegen

Phase 3 Completed
25 enrolled

Paget Disease, Extramammary

NCT02329171 2018-08-15

TOPIC

Maastricht University Medical Center

Phase 3 Terminated
9 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT02669459 2018-02-06

TopIC-2

Erasmus Medical Center

Phase 3 Unknown
433 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT01283763 2016-11-01

ITIC2

Medical University of Vienna

Phase 3 Terminated
95 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00175643 2006-05-09

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

University of British Columbia

Phase 3 Completed
20 enrolled
DermatologicOther neoplasm

Carcinoma, Squamous Cell, Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡